Cancer Awareness in Atypical Thrombotic Microangiopathies-Reference-Cited by-同舟云学术

Cancer Awareness in Atypical Thrombotic Microangiopathies

Published:2009-08-01 Issue:8 Volume:14 Page:769-779
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Oberic Lucie¹,Buffet Marc¹,Schwarzinger Mickael²,Veyradier Agnès³,Clabault Karine⁴,Malot Sandrine¹,Schleinitz Nicolas⁵,Valla Dominique⁶,Galicier Lionel⁷,Bengrine-Lefèvre Leila⁸,Gorin Norbert-Claude¹,Coppo Paul¹,

Affiliation:

1. Service d’Hématologie et de Thérapie Cellulaire, Hôpital Saint-Antoine, Université Pierre et Marie Curie (UPMC), Paris, France

2. Institut National de la Santé et de la Recherche Médicale (INSERM) UMR-S 707, Faculté de Médecine Saint-Antoine, Paris, France

3. Service d’Hématologie Biologique, AP-HP, Hôpital Antoine Béclère, Clamart, et Université Paris-Sud 11, Le Kremlin-Bicêtre, France

4. Service de Réanimation Médicale, Hôpital Charles Nicolle, Rouen, France

5. Service de Médecine Interne, Hôpital de la Conception, Marseille, France

6. Service d’Hépatologie, AP-HP, Hôpital Beaujon, Paris, France

7. Service d’Immunopathologie, AP-HP, Hôpital Saint-Louis, Paris, France

8. Service d’Oncologie Médicale, Assistance Publique–Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Université Pierre et Marie Curie (UPMC), Paris, France

Abstract

Learning Objectives After completing this course, the reader will be able to: Outline the clinical and biological features that would prompt a clinician to investigate an underlying malignancy in a patient suffering from thrombotic microangiopathy.Conduct additional investigation to diagnose or rule out malignancy.Formulate in timely fashion an adapted treatment plan for a patient with a cancer-associated thrombotic microangiopathy. This article is available for continuing medical education credit at CME.TheOncologist.com.

Funder

Etablissement Français du Sang

GIS-Institut des Maladies Rares

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2009-0067

Reference34 articles.

1. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome;Furlan;N Engl J Med,1998

2. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura;Tsai;N Engl J Med,1998